- Home
- APLT vs LITM Comparison
APLT vs LITM Comparison
Compare APLT & LITM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- LITM
- Stock Information
- Founded
- APLT 2016
- LITM 2018
- Country
- APLT United States
- LITM Canada
- Employees
- APLT N/A
- LITM N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- LITM Other Metals and Minerals
- Sector
- APLT Health Care
- LITM Basic Materials
- Exchange
- APLT Nasdaq
- LITM Nasdaq
- Market Cap
- APLT 37.5M
- LITM 42.2M
- IPO Year
- APLT 2019
- LITM 2021
- Fundamental
- Price
- APLT $0.33
- LITM $0.41
- Analyst Decision
- APLT Buy
- LITM
- Analyst Count
- APLT 7
- LITM 0
- Target Price
- APLT $6.10
- LITM N/A
- AVG Volume (30 Days)
- APLT 2.3M
- LITM 10.0M
- Earning Date
- APLT 04-14-2025
- LITM 04-29-2025
- Dividend Yield
- APLT N/A
- LITM N/A
- EPS Growth
- APLT N/A
- LITM N/A
- EPS
- APLT N/A
- LITM N/A
- Revenue
- APLT $455,000.00
- LITM N/A
- Revenue This Year
- APLT $3,031.87
- LITM N/A
- Revenue Next Year
- APLT $312.01
- LITM N/A
- P/E Ratio
- APLT N/A
- LITM N/A
- Revenue Growth
- APLT N/A
- LITM N/A
- 52 Week Low
- APLT $0.30
- LITM $0.15
- 52 Week High
- APLT $10.62
- LITM $1.88
- Technical
- Relative Strength Index (RSI)
- APLT 36.05
- LITM 41.02
- Support Level
- APLT $0.30
- LITM $0.39
- Resistance Level
- APLT $0.38
- LITM $0.55
- Average True Range (ATR)
- APLT 0.05
- LITM 0.06
- MACD
- APLT -0.00
- LITM -0.00
- Stochastic Oscillator
- APLT 17.19
- LITM 16.46
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About LITM Snow Lake Resources Ltd.
Snow Lake Resources Ltd is a Canadian clean energy exploration company with a world-wide portfolio of clean energy mineral projects comprised of two uranium projects and two hard rock lithium projects. Its Projects include: The Black Lake Uranium Project, the Engo Valley Uranium Project, The Shatford Lake Project, and the Snow Lake Lithium Project.